0.7660
-0.0635
(-7.66%)
At close: January 10 at 7:30:23 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-43,080.0000
-62,054.0000
-60,079.0000
-47,941.0000
-14,709.0000
Investing Cash Flow
-6,094.0000
3,077.0000
-16,967.0000
-1,816.0000
-307.0000
Financing Cash Flow
34,702.0000
20,881.0000
59,475.0000
120,676.0000
31,611.0000
End Cash Position
39,005.0000
39,462.0000
77,563.0000
95,109.0000
24,190.0000
Capital Expenditure
-6,094.0000
-10,476.0000
-4,457.0000
-939.0000
-307.0000
Issuance of Capital Stock
--
20,804.0000
59,567.0000
129,211.0000
37,822.0000
Issuance of Debt
--
500.0000
500.0000
--
921.0000
Repayment of Debt
--
--
--
-10.0000
-5,649.0000
Free Cash Flow
-49,174.0000
-72,530.0000
-64,536.0000
-48,880.0000
-15,016.0000
12/31/2020 - 2/6/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1FW1.MU WuXi Biologics (Cayman) Inc
4.6400
+13.17%
NRXS NeurAxis, Inc.
2.4900
0.00%
5CV.MU CureVac NV
4.0800
+3.82%
WXXWY WuXi Biologics (Cayman) Inc.
4.2900
+2.39%
NRX.V NurExone Biologic Inc.
0.6800
+4.62%
CNTB Connect Biopharma Holdings Limited
1.0800
-6.09%
TRVI Trevi Therapeutics, Inc.
3.8200
-5.21%
MDWD MediWound Ltd.
16.72
+4.43%
KRYS Krystal Biotech, Inc.
152.92
-2.39%
TERN Terns Pharmaceuticals, Inc.
5.01
-4.48%